scispace - formally typeset
G

Galina Gergova

Researcher at Sofia Medical University

Publications -  44
Citations -  1119

Galina Gergova is an academic researcher from Sofia Medical University. The author has contributed to research in topics: Helicobacter pylori & Clarithromycin. The author has an hindex of 20, co-authored 42 publications receiving 986 citations.

Papers
More filters
Journal ArticleDOI

Activity of Bulgarian propolis against 94 Helicobacter pylori strains in vitro by agar-well diffusion, agar dilution and disc diffusion methods.

TL;DR: Bulgarian propolis had a strong and dose-dependent activity against most of the H. pylori strains tested and the effect of propolis on H.pylori in vitro is promising, further microbiological, pharmacological and clinical trials are required.
Journal ArticleDOI

Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods

TL;DR: The increasing clarithromycin resistance and presence of multidrug resistance are worrying and fluoroquinolones should be used with caution for H. pylori eradication in treated patients.
Journal ArticleDOI

Anaerobic microbiology in 198 cases of pleural empyema: a Bulgarian study.

TL;DR: The wide diversity of isolated anaerobic genera and species and the susceptibility patterns of the isolates emphasize the role of the an aerobic microbiology in cases of pleural empyema.
Journal ArticleDOI

Campylobacter infection in 682 bulgarian patients with acute enterocolitis, inflammatory bowel disease, and other chronic intestinal diseases.

TL;DR: The involvement of Campylobacter infection in relapses of chronic intestinal disorders and the susceptibility patterns of the strains strongly emphasize the role of Campyobacter as a cause of infection in this group of patients.
Journal ArticleDOI

Anaerobic bacteria in 118 patients with deep-space head and neck infections from the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria

TL;DR: In conclusion, the start of empirical treatment could influence the frequency or rate of isolation of Fusobacterium species, and the involvement of the Bacteroides fragilis group in some head and neck infections should be considered.